Pipethanate ethobromide

Drug #2164

Pipethanate ethobromide is an antimuscarinic with actions similar to those of atropine.

← Previous drug Next drug →

Primary Characteristics

Non-proprietary name: Pipethanate ethobromide.

Molecular structure of Pipethanate ethobromide

Pharmacokinetics

None recorded.

Indications

Pipethanate ethobromide is primarily indicated in conditions like Gastritis, Gastrointestinal spasm, Visceral spasms.

Contraindications

Pipethanate ethobromide is contraindicated in conditions like Paralytic ileus, Close-angle glaucoma, Pyloric stenosis.

Dosage

Pipethanate ethobromide's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
15 mg	15 mg	—	IM	daily.
160 mg	160 mg	—	PO	should be given in divided doses.
90 mg	90 mg	—	PR	dialy.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Pipethanate ethobromide in overdosage may give rise to further complications which include Deaths .

The signs and symptoms that are produced after acute overdosage of Pipethanate ethobromide are Nausea, Confusion , Incoordination , Ataxia, Vomiting, Rashes , Paranoid psychosis, Excitement, CNS stimulation, Increased respiration rate, Hallucinations .

Warnings / Precautions

Should be use with caution in patients with diarrhea, myasthenia gravis, fever, tachycardia, cardiac surgery, may cause mental confusion.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Inj

10 mg

Tabs

10 mg

Drug Classification

1.4.2.3 — Organophosphate and carbamate poisoning
2.17.5 — Antispasmodics

Manufacturers

Manufacturers of Pipethanate ethobromide in Pakistan:

Sharex